August Bioservice, a Nashville, TN-based Contract Development and Manufacturing Organization, raised $65M in Series B funding.
The round was led by Oak HC/FT, with participation from Polaris Partners.
Led by CEO Jenn Adams, August Bioservices is a contract development and manufacturing organization (CDMO) providing drug discovery, development and pharmaceutical manufacturing services. The company partners with biopharmaceutical and biotech companies to provide a wide array of services that help to accelerate the advancement of novel therapeutics along the drug development pathway.
The company intends to use the funds to add capacity for large batch sterile pharmaceutical manufacturing. August will add an additional sterile injectable filling suite to support high-speed liquid vial filling. This expansion will add incremental capacity for production of large batches, enabling the company to meet the pharmaceutical manufacturing needs for customers of all sizes. In addition, August will fully automate downstream inspection, labeling and packaging processes in support of the increased throughput.
FinSMEs
02/12/2022